Search

everythinglearnresearchcommunity

for

Search:↓

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Early onset hair loss is linked to low vitamin D, but severity isn't related to vitamin D levels.

The document concludes that there are various treatments for diseases linked to scarring hair loss, especially for primary scarring alopecia.

Male pattern baldness may increase COVID-19 severity risk.

Anterolateral leg alopecia is a benign, nonprogressive hair loss condition on the lower legs that is not well understood and may resolve on its own.

Baldness is often hereditary and linked to male hormones, becoming noticeable when half the hair is lost.

Male pattern baldness affects social interactions and mental health, and while treatments are being explored, hair transplants are currently the most effective solution.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Oral minoxidil effectively treats different types of hair loss with fewer side effects.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

New oral treatment, finasteride, effectively and safely treats common hair loss.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Men with early baldness often have low vitamin D levels.